首页> 外文期刊>Biotechnology Journal: Healthcare,Nutrition,Technology >Patentability of synthetic biology inventions in Europe
【24h】

Patentability of synthetic biology inventions in Europe

机译:欧洲合成生物学发明的专利性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Patents give the inventor exclusive rights over his invention for a limited time. This provides an incentive and securities for bringing new and innovative products to the market. Patents also prevent secrecy and provide freely accessible technical knowledge because they are published 18 months after their filing. The European Patent Convention (EPC) constitutes the legal framework for the granting of patents in all fields of technology in its 36 member states [1]. Inventions can be patented if they are novel, involve an inventive step (i.e. are not obvious over the state of the art) and are susceptible to industrial application. Some subject- scientific theories, or programs for computers as such, are not regarded as inventions and can thus not be patented. Also the patenting of subject-matter which would be contrary to "ordre public" or morality is exempted. This prevents for example the patenting of a letter-bomb or of (synthetic) biological weapons.
机译:专利授予发明人有限时间的发明专有权。这为将创新产品推向市场提供了动力和保证。专利还可以防止保密,并提供免费获取的技术知识,因为专利是在专利提交18个月后发布的。欧洲专利公约(EPC)构成了其36个成员国中在所有技术领域授予专利的法律框架[1]。如果发明是新颖的,涉及发明性的步骤(即在现有技术中不是显而易见的)并且易于工业应用,则可以申请专利。一些主题科学理论或此类计算机程序不被视为发明,因此不能申请专利。同样,与“公共道德”或道德背道而驰的主题专利申请也被豁免。例如,这会阻止对炸弹或(合成)生物武器申请专利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号